Zinzino: ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2020

Solid sales growth during October; Zinzino group revenue increased with a total of 21%, compared with the previous year.

The revenue in October for Zinzino's sales markets increased by 18% to SEK 100.8 (85.1) million primarily due to strong growth foremost in Central Europe. Faun Pharma's external sales increased by 63% and amounted to SEK 7.0 (4.3) million. Overall, the Group increased revenues by 21% to SEK 107.8 (89.4) million compared with the previous year.

Accumulated revenue for January - October 2020 increased by 45% SEK 906.1 (623.2) million.

Revenues distributed as follows:

Regions,MSEK 20-Oct 19-Oct Change YTD 2020 YTD 2019 Change
Nordic Markets 33.9 45.3 -25% 323.6 319.0 1%
Europe Other Markets 52.2 29.2 79% 423.8 192.9 120%
Baltic Markets 6.3 5.8 9% 55.1 45.0 22%
North America 3.8 2.9 31% 30.8 19.6 57%
APAC 4.6 1.9 142% 23,.6 6.6 258%
Zinzino 100.8 85.1 18% 856.9 583.1 47%
Faun Pharma 7.0 4.3 63% 49.2 40.1 23%
Zinzino Group 107.8 89.4 21% 906.1 623.2 45%
 

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
Marcus Tollbom +46 (0) 70 190 03 12, marcus.tollbom@zinzino.com

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se

 

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 13:00 the 3rd of November 2020.

 

Zinzino AB (publ.) is a global Direct Sales company that markets and sells test-based nutrition, skincare and life-style products. Zinzino owns the research unit BioActive Foods AS and production unit Faun Pharma AS. Zinzino is based in Gothenburg, with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong and Malaysia. Zinzino is a public company and its shares are listed on Nasdaq First North Premier Growth Market.

Source: Cision
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

  • Full tillgång till di.se med nyheter och analyser

  • Tillgång till över 1100 aktiekurser i realtid

  • Innehållet i alla Di:s appar, tjänster och nyhetsbrev

3 månader för
197 kr
Spara 1000 kr

Prenumerera

Redan prenumerant?